Tabrecta Tablet, Film Coated
Product Images NDC 0078-0709
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tabrecta (NDC 0078-0709). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel Ndc 0078-0709-56 Tabrecta™ (capmatinib) Tablets 150 mg* Attention: Dispense And Store Tabrecta In Original Container With The Desiccant To Protect From Moisture. Rx Only 56 Film-coated Tablets Novartis (Inc280 02)
Principal Display Panel Ndc 0078-0716-56 Tabrecta™ (capmatinib) Tablets 200 mg* Attention: Dispense And Store Tabrecta In Original Container With The Desiccant To Protect From Moisture. Rx Only 56 Film-coated Tablets Novartis (Inc280 03)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.